Conjunctivitis, Allergic: all 231 studies
Page 2 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen AllergyTerminatedNCT07309432Phase 3
- Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical SteroidsActive, not recruitingNCT06913790
- Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film DysfunctionCompletedNCT06800274Phase 4
- A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen AllergyCompletedNCT06602739Phase 3
- A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat AllergyCompletedNCT06602726Phase 3
- A Study Of TL-925 For The Treatment of ACCompletedNCT06293820Phase 2
- A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsCompletedNCT06212973Phase 3
- Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenCompletedNCT06063044
- A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy AdultsCompletedNCT05969236Phase 1
- PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"CompletedNCT05829499Not applicable
- PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops"CompletedNCT05824000Not applicable
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 1
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic ConjunctivitisCompletedNCT05314621Phase 4
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic ConjunctivitisCompletedNCT05265910Phase 4
- Tyrosine Allergoid Paediatric and Adult StudyActive, not recruitingNCT05186025
- Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal KeratoconjunctivitisCompletedNCT05076084
- HORMONES IN VERNAL KERATOCONJUNCTIVITISCompletedNCT05038241
- Probiotic Chewables in Allergic Rhinoconjunctivitis PatientsCompletedNCT04898686Not applicable
- Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in ChildrenCompletedNCT04810390Phase 3
- Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis TreatmentCompletedNCT04776096Phase 4
- DEXTENZA Therapy for Treatment of Allergic ConjunctivitisCompletedNCT04708821Phase 4
- Topical Immuonosuppressant Drugs in Spring CatarrhStatus unknownNCT04705584Not applicable
- Sea Water in Allergic ConjunctivitisStatus unknownNCT04695795
- Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EECCompletedNCT04641130Not applicable
- Airway Immune Response to Allergens (Use Lay Language Here)Active, not recruitingNCT04619017Phase 1
- Therapeutic Effect of Tacrosolv in Patients With Allergic RhinoconjunctivitisCompletedNCT04532710Phase 2
- Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) LevelsCompletedNCT04389034
- Corneal Biomechanical Changes of Allergic ConjunctivitisStatus unknownNCT04299399
- Manuka Eye Droops for Treatment of AllergyWithdrawnNCT03862053Phase 4
- Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic ManifestationsCompletedNCT03861910
- Diagnostic Equivalence of the Skin Prick Test Tape vs. Conventional Skin PrickTestStatus unknownNCT03820154Not applicable
- China Red Eye Study on Allergic ConjunctivitisStatus unknownNCT03812952
- Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal SprayCompletedNCT03755557Phase 3
- Molekule for Allergic Rhinitis/AsthmaTerminatedNCT03627689Not applicable
- Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic KeratoconjunctivitisStatus unknownNCT03557203
- A Novel Combined Therapy for Refractory Vernal KeratoconjunctivitisCompletedNCT03464435Phase 4
- A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic ConjunctivitisCompletedNCT03379311Phase 1
- Evaluation of Subcutaneous Immunotherapy Towards Pollen in ChildrenCompletedNCT03375775Not applicable
- Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic ConjunctivitisCompletedNCT03368339Phase 2
- Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in PediatricsCompletedNCT03365648Not applicable
- Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic ConjunctivitisStatus unknownNCT03186755Phase 4
- Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal ReseachersCompletedNCT03101618
- Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node InjectionsTerminatedNCT03038971Phase 1
- Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust MitesCompletedNCT02881879Phase 1
- Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in KoreaCompletedNCT02555761
- Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte ExtractsCompletedNCT02506998Phase 2
- A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic ConjunctivitisCompletedNCT02492321Phase 3
- A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure ChamberCompletedNCT02481856Phase 2
- Topical Tacrolimus in Vernal KeratoconjunctivitisStatus unknownNCT02456025Phase 4
- Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EECCompletedNCT02271009Phase 2
- Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
- A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)CompletedNCT02082899Phase 2
- Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 MonthsStatus unknownNCT02057822
- The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy ReactionsStatus unknownNCT01878929Phase 1/2
- Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic ConjunctivitisTerminatedNCT01860664Phase 2
- Ocular Allergy Treatment Practical Impact TrialStatus unknownNCT01808768Phase 4
- Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic RhinoconjunctivitisCompletedNCT01731249Phase 3
- The Significance of Ambrosia in Allergic Rhinitis and Asthma in IsraelCompletedNCT01686048
- Evaluating Patients With Eye Allergies and Determining if There Are Also Dry EyesCompletedNCT01679015
- Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic ConjunctivitisWithdrawnNCT01657240Phase 3
- Evaluation of the Onset and Duration of Action of RX-10045 in Allergic ConjunctivitisCompletedNCT01639846Phase 2
- An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic ConjunctivitisCompletedNCT01561521Phase 3
- Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic ConjunctivitisWithdrawnNCT01541904Phase 2
- Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal RhinoconjunctivitisCompletedNCT01490411Phase 2
- Subcutaneous Immunotherapy in Patients Sensitized to Phleum PratenseCompletedNCT01489033Phase 1
- The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to PlaceboCompletedNCT01471184Not applicable
- Vitamin D and Grass Pollen Specific ImmunotherapyCompletedNCT01466465Phase 2
- A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%CompletedNCT01437982Phase 4
- Comparison of Tolerability Between Two Allergy DropsStatus unknownNCT01390961Phase 4
- Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and AdolescentsCompletedNCT01342601Not applicable
- A Patient Reported Ocular Comfort Assessment Comparing Bepreve to LastacaftCompletedNCT01339507
- Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact LensesStatus unknownNCT01337557Phase 4
- Safety and Comfort of AL-4943A Ophthalmic SolutionCompletedNCT01326858Phase 1
- Patient Perception Study for AL-4943ACompletedNCT01294969Phase 4
- A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.TerminatedNCT01287338Phase 2
- A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)CompletedNCT01275105Phase 2
- A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic ConjunctivitisCompletedNCT01272089Phase 4
- Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic ConjunctivitisCompletedNCT01258309Phase 3
- Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in RwandaCompletedNCT01211327Phase 4
- Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis PatientsCompletedNCT01203540Phase 4
- Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic ConjunctivitisCompletedNCT01120132Phase 2
- Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric PatientsCompletedNCT01109485Phase 4
- Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)CompletedNCT01081574Phase 1/2
- Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)CompletedNCT01068054Phase 2/3
- PURETHAL Grasses Rush StudyCompletedNCT01059266Phase 4
- An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic ConjunctivitisCompletedNCT01037179Phase 3
- A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen ExtractsStatus unknownNCT01012752Phase 3
- AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated InflammationCompletedNCT01001091Phase 2
- Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese SubjectsCompletedNCT00987272Phase 3
- Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)CompletedNCT00985296
- A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCubeCompletedNCT00985075
- A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed SeasonCompletedNCT00982163
- Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).CompletedNCT00917488Phase 2
- To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen ChallengeWithdrawnNCT00881673Phase 2
- Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic ConjunctivitisCompletedNCT00836485Phase 2
- Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic InflammationCompletedNCT00833495Phase 2
- Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic RhinoconjunctivitisCompletedNCT00833066Phase 1/2
- Long-term Efficacy and Safety Study With Oralgen Grass PollenCompletedNCT00824447Phase 2/3
- Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic RhinitisCompletedNCT00813046Phase 1
- A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen RhinoconjunctivitisStatus unknownNCT00812799Phase 3